Page 19 - Diagnosis and clinical consequences of cachexia in patients with advanced cancer Susanne Blauwhoff-Buskermolen
P. 19
References 1
1. Muscaritoli M, Anker SD, Argiles J, Aversa Z, Bauer JM, Biolo G, Boirie Y, Bosaeus I, Cederholm T, Costelli P et al. Consensus de nition of sarcopenia, cachexia and pre-cachexia: joint document elaborated by Special Interest Groups (SIG) “cachexia-anorexia in chronic wasting diseases” and “nutrition in geriatrics”. Clin Nutr 2010;29:154-9.
2. Fearon K, Strasser F, Anker SD, Bosaeus I, Bruera E, Fainsinger RL, Jatoi A, Loprinzi C, MacDonald N, Mantovani G et al. De nition and classi cation of cancer cachexia: an international consensus. Lancet Oncol 2011;12:489-95.
3. Netherlands Comprehensive Cancer Organisation. Statistics on cancer by the Netherlands Cancer Registry. 1-4-2016.
4. Roger Woodruff. Palliative Medicine: Evidence-based symptomatic and supportive care for patients with advanced cancer. Oxford University Press, 2004.
5. McIllmurray M, Hoskin PJ, Krouse RS. Disease-modifying management in advanced cancer. In: Kaasa S, Cherny NI, Hanks G, eds. Oxford Textbook of Palliative Medicine. Oxford: Oxford University Press 2011:513-84.
6. Rana MV, Candido KD, Raja O, Knezevic NN. Celiac plexus block in the management of chronic abdominal pain. Curr Pain Headache Rep 2014;18:394.
7. Walsh D, Donnelly S, Rybicki L. The symptoms of advanced cancer: relationship to age, gender, and performance status in 1,000 patients. Support Care Cancer 2000;8:175-9.
8. Laugsand EA, Sprangers MAG, Bjordal K, Skorpen F, Kaasa S, Klepstad P. Health care providers underestimate symptom intensities of cancer patients: a multicenter European study. Health Qual Life Outcomes 2010;8:104.
9. JohnsenAT,Petersen MA,Pedersen L,Groenvold M.Symptoms and problems in a nationally representative sample of advanced cancer patients. Palliat Med 2009;23:491-501.
10. Tong H, Isenring E,Yates P.The prevalence of nutrition impact symptoms and their relationship to quality of life and clinical outcomes in medical oncology patients. Support Care Cancer 2009;17:83-90.
11. Ravasco P, Monteiro-Grillo I,Vidal PM, Camilo ME. Cancer: disease and nutrition are key determinants of patients’ quality of life. Support Care Cancer 2004;12:246-52.
12. Thoresen L, Frykholm G, Lydersen S, Ulveland H, Baracos V, Birdsell L, Falkmer U. The association of nutritional assessment criteria with health-related quality of life in patients with advanced colorectal carcinoma. Eur J Cancer Care (Engl ) 2012;21:505-16.
13. Mendes MC, Pimentel GD, Costa FO, Carvalheira JBC. Molecular and neuroendocrine mechanisms of cancer cachexia. J Endocrinol 2015;226:R29-R43.
14. Wigmore SJ, Todorov PT, Barber MD, Ross JA, Tisdale MJ, Fearon KC. Characteristics of patients with pancreatic cancer expressing a novel cancer cachectic factor. Br J Surg 2000;87:53-8.
15. Loumaye A, de Barsy M, Nachit M, Lause P, Frateur L, van Maanen A,Trefois P, Gruson D,Thissen JP. Role of Activin A and myostatin in human cancer cachexia. J Clin Endocrinol Metab 2015;100:2030-8.
16. Chen JL, Walton KL, Winbanks CE, Murphy KT, Thomson RE, Makanji Y, Qian H, Lynch GS, Harrison CA, Gregorevic P. Elevated expression of activins promotes muscle wasting and cachexia. FASEB J 2014;28:1711-23.
17. Bing C, BaoY, Jenkins J, Sanders P, Manieri M, Cinti S,Tisdale MJ,Trayhurn P. Zinc-alpha2-glycoprotein, a lipid mobilizing factor, is expressed in adipocytes and is up-regulated in mice with cancer cachexia. Proc Natl Acad Sci U S A 2004;101:2500-5.
18. Mracek T, Stephens NA, Gao D, Bao Y, Ross JA, Ryden M, Arner P, Trayhurn P, Fearon KCH, Bing C. Enhanced ZAG production by subcutaneous adipose tissue is linked to weight loss in gastrointestinal cancer patients. Br J Cancer 2011;104:441-7.
19. Asakawa A, Fujimiya M, Niijima A, Fujino K, Kodama N, Sato Y, Kato I, Nanba H, Laviano A, Meguid MM et al. Parathyroid hormone-related protein has an anorexigenic activity via activation of hypothalamic urocortins 2 and 3. Psychoneuroendocrinology 2010;35:1178-86.
20. Ezeoke CC, Morley JE. Pathophysiology of anorexia in the cancer cachexia syndrome. J Cachexia Sarcopenia Muscle 2015;6:287-302.
General introduction
17
